Funded Tech Companies
Ascenta Therapeutics
Wondering who provided funding to Ascenta Therapeutics? U.S. Venture Partners, Domain Associates and Enterprise Partners Venture Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Ascenta Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
101 Lindenwood Dr. 405
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Company Background Information
Overview
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2008
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mel Sorensen
Chief Financial Officer
Joel Sussman
VP - Bus. Development
Brian Wood
VP - Operations
Jeffrey Brill
Company Investors
- U.S. Venture Partners
- Domain Associates (Eckard Weber)
- Enterprise Partners Venture Capital (Drew Senyei)
- Scale Venture Partners (Lou Bock)
- Sofinnova Ventures (Michael Powell)
- Perseus (Norman Selby)
- U.S. Venture Partners (Jonathon Root)
- Domain Associates (Eckhard Weber)
- U.S. Venture Partners (Jonathan Root)
- Domain Associates ( Dr. Eckard Weber)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs